Home » Topics » Science » Drug design, drug delivery and technologies

Drug design, drug delivery and technologies
RSS

Antibody-based collaborative agreement reached by CaT and Lilly

Jan. 10, 1997

Bristol-Myers Squibb/Cadus collaboration extended

Jan. 10, 1997

Sequana and Glaxo Wellcome alliance

Jan. 9, 1997

Progenitor's functional genomics program advances

Jan. 9, 1997

Drug discovery collaboration agreement signed by Houghten, Chugai

Jan. 9, 1997

Caliper Technologies technology useful in drug discovery

Jan. 8, 1997

Genzyme Transgenics, BASF forge agreement for transgenic production of biopharmaceuticals

Jan. 8, 1997

Breath-activated inhaler from IVAX licensed to Glaxo Wellcome

Dec. 31, 1996

Endorex licenses oral delivery technology

Dec. 24, 1996

Novel adenylate cyclase offered for licensing

Dec. 20, 1996

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for July 23, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for July 21, 2026
To viral or not to viral: In vivo CAR T debates delivery tech
BioWorld
The field of cell and gene therapy is moving toward a new phase of scalability and clinical durability, with in vivo chimeric antigen receptor (CAR) T-cell...
KBN-2201 reverses key features of Alzheimer’s in mice
BioWorld Science
Researchers from Ajou University School of Medicine reported the preclinical efficacy of KBN-2201 in a mouse model of late-stage Alzheimer’s disease.
In vivo click ADCs could address tumor heterogeneity
BioWorld
Researchers at Washington University in St. Louis have used click chemistry to link a second antibody to a pre-existing antibody-drug conjugate (ADC) in vivo. In...